Literature DB >> 27932062

Experiencing neonatal maternal separation increased pain sensitivity in adult male mice: Involvement of oxytocinergic system.

Hossein Amini-Khoei1, Shayan Amiri2, Ali Mohammadi-Asl3, Sakineh Alijanpour4, Simin Poursaman3, Arya Haj-Mirzaian5, Mojgan Rastegar2, Azam Mesdaghinia6, Hamid Reza Banafshe7, Ehsanollah Sadeghi8, Elika Samiei3, Shahram Ejtemaie Mehr5, Ahmad Reza Dehpour9.   

Abstract

Early-life stress adversely affects the development of the brain, and alters a variety of behaviors such as pain in later life. In present study, we investigated how early-life stress (maternal separation or MS) can affect the nociceptive response later in life. We particularly focused on the role of oxytocin (OT) in regulating nociception in previously exposed (MS during early postnatal development) mice that were subjected to acute stress (restraint stress or RS). Further, we evaluated whether such modulation of pain sensation in MS mice are regulated by shared mechanisms of the OTergic and opioidergic systems. To do this, we assessed the underlying systems mediating the nociceptive response by administrating different antagonists (for both opioid and OTergic systems) under the different experimental conditions (control vs MS, and control plus RS vs MS plus RS). Our results showed that MS increased pain sensitivity in both tail-flick and hot-plate tests while after administration of OT (1μg/μl/mouse, i.c.v) pain threshold was increased. Atosiban, an OT antagonist (10μg/μl/mouse, i.c.v) abolished the effects of OT. While acute RS increased the pain threshold in control (and not MS) mice, treating MS mice with OT normalized the pain response to RS. This latter effect was reversed by atosiban and/or naltrexone, an opioid antagonist (0.5μg/μl/mouse, i.c.v) suggesting that OT enhances the effect of endogenous opioids. OTergic system is involved in mediating the nociception under acute stress in mice subjected to early-life stress and OTergic and opioidergic systems interact to modulate pain sensitivity in MS mice.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute restraint stress; Maternal separation; Opioid; Oxytocin; Pain threshold

Mesh:

Substances:

Year:  2016        PMID: 27932062     DOI: 10.1016/j.npep.2016.11.005

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  6 in total

Review 1.  Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.

Authors:  Michael T Bardo; Lindsey R Hammerslag; Samantha G Malone
Journal:  Neuropharmacology       Date:  2021-04-13       Impact factor: 5.273

2.  The effect of intra-cerebroventricular injection of insulin on the levels of monoamines on the raphe magnus nucleus of non-diabetic and short-term diabetic rats in the formalin test.

Authors:  Shima Balali Dehkordi; Javad Sajedianfard; Ali Akbar Owji
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

3.  Progesterone exerts antidepressant-like effect in a mouse model of maternal separation stress through mitigation of neuroinflammatory response and oxidative stress.

Authors:  Ali Nouri; Farzaneh Hashemzadeh; Amin Soltani; Elham Saghaei; Hossein Amini-Khoei
Journal:  Pharm Biol       Date:  2020-01-01       Impact factor: 3.503

4.  ΔMST and the Regulation of Cardiac CSE and OTR Expression in Trauma and Hemorrhage.

Authors:  Britta Trautwein; Tamara Merz; Nicole Denoix; Csaba Szabo; Enrico Calzia; Peter Radermacher; Oscar McCook
Journal:  Antioxidants (Basel)       Date:  2021-02-03

5.  Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.

Authors:  Courtney M Cameron; Steven Nieto; Lucienne Bosler; Megan Wong; Isabel Bishop; Larissa Mooney; Catherine M Cahill
Journal:  Adv Drug Alcohol Res       Date:  2021-08-03

6.  Intranasal Oxytocin following Uncontrollable Stress Blocks Impairments in Hippocampal Plasticity and Recognition Memory in Stressed Rats.

Authors:  Seong-Hae Park; Yoon-Jung Kim; Jung-Cheol Park; Jung-Soo Han; Se-Young Choi
Journal:  Int J Neuropsychopharmacol       Date:  2017-10-01       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.